The odds of midlife NAFLD were also significantly higher when apoB was lower than the median and TG was greater than the median, suggesting that low apoB levels may be a precipitating factor in NAFLD or subclinical NAFLD. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.